CLINICAL_TRIALS
trial_result
· 2021-12-28
Clinical Trial Update: Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas [Phase 3]
Summary
Phase 3 trial investigating oral corticosteroids for chronic subdural hematoma was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Montpellier | Conditions: Chronic Intracranial Subdural Hematoma | Phase 3 | Status: TERMINATED